Jorey Chernett Reports 9.9% Ownership Stake in Exagen Inc. (XGN)

On May 20, 2026, Jorey Chernett filed a Schedule 13G/A disclosing a significant new ownership position in Exagen Inc. (XGN). As of the event date of March 31, 2026, and updated through May 19, 2026, the reporting person beneficially owns 2,413,901 shares of Common Stock. This represents a 9.9% ownership stake in the company based on 24,159,839 shares outstanding as of May 6, 2026. The filing indicates that the reporting person holds sole voting and dispositive power over all 2,413,901 shares. This is an amendment to a previous filing, reflecting an increase from a 0.0% reported position to the current 9.9% threshold. The shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. Jorey Chernett is an individual investor based in Bloomfield Hills, Michigan. The total market value of the holdings is estimated at approximately $9,003,850.73 based on recent data.